Public Profile

Pahc

Pahc, or Pahc Inc., is a leading player in the healthcare technology industry, headquartered in the United States. Founded in 2005, the company has established a strong presence across North America, focusing on innovative solutions that enhance patient care and streamline healthcare operations. Pahc is renowned for its cutting-edge software and services, which include electronic health records (EHR), telehealth platforms, and data analytics tools. These offerings are distinguished by their user-friendly interfaces and robust integration capabilities, setting Pahc apart from competitors. With a commitment to improving healthcare delivery, Pahc has achieved significant milestones, including partnerships with major healthcare providers and recognition for its contributions to digital health transformation. As a trusted name in the industry, Pahc continues to shape the future of healthcare technology.

DitchCarbon Score

How does Pahc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

33

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Pahc's score of 33 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

63%

Let us know if this data was useful to you

Pahc's reported carbon emissions

In 2023, Pahc reported total carbon emissions of approximately 47,932,000 kg CO2e, comprising 31,898,000 kg CO2e from Scope 1 and 16,034,000 kg CO2e from Scope 2 emissions. This marks an increase from 2022, when total emissions were about 43,135,000 kg CO2e, with Scope 1 at 27,297,000 kg CO2e and Scope 2 at 15,838,000 kg CO2e. Pahc has set ambitious climate commitments, aiming to reduce its Scope 1 emissions by 30% from a 2021 baseline by 2030. Additionally, the company plans to reduce its Scope 2 emissions by the same percentage within the same timeframe. Furthermore, Pahc aims to bring its Scope 1 and Scope 2 emissions close to zero by the middle of this decade, demonstrating a strong commitment to climate action and sustainability. Overall, Pahc's emissions reduction strategy reflects a proactive approach to addressing climate change, aligning with industry standards and expectations for corporate responsibility.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2020202120222023
Scope 1
23,341,000
00,000,000
00,000,000
00,000,000
Scope 2
14,420,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pahc's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Pahc is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pahc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Huvepharma EOOD

BG
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Idexx Laboratories

US
Research and development services (73)
Updated 16 days ago

Southeastern Minerals, Inc.

US
Animal products nec
Updated 23 days ago

Boehringer Ingelheim International GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Merck And Co

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Huvepharma N.V.

NL
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers